HALO-TRIAL: High, Medium And LOw Intensity Psychotherapy for Binge Eating Disorder
Recruiting · NCT07698132 · Interventional (participants receive a specific treatment) · Lead sponsor: Herlev and Gentofte Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in reducing the number of binge-eating episodes in people with the eating disorder Binge Eating Disorder (BED), by directly comparing three intensities of Cognitive Behavioral Therapy-Enhanced against a manualized treatment as usual. Participants will be asked to complete a 21-weeks randomized intervention and participate in follow up assesments.
Who can take part
Inclusion criteria
- Binge Eating Disorder according to DSM-5 criteria
- 18-65 years of age
- Fluent Danish speaker
Exclusion criteria
- Concurrent psychotherapeutic treatment
- Use of weight loss medications within the last month (i.e., GLP-1 receptor antagonists)
- Suicidal ideation or suicidality
- Psychosis or psychotic disorders
- Mania or bipolar disorder
- Drug misuse disorder
- Alcohol misuse disorder
- Cluster B personality disorders in the severe range (diagnosed)
- Dosage of Antidepressants, Antipsychotics and Stimulants must be stable for at least 6 months
Where it is running
1 location listed.
- Mental Health Centre Ballerup - Ballerup Municipality, Capital Region, Denmark